Onchocercal nodules were stained immunohistochemically using antibodies spe
cific for human mast cells and IgE to elucidate the localization and freque
ncy of mast cells after a single oral dose of 150 mu g/kg ivermectin. Trypt
ase-and chymase-positive mast cells occurred predominantly in mixed inflamm
atory infiltrates and perivascularly, and never adhered to adult worms or m
icrofilariae. Up to three days after ivermectin, mast cells and IgE-positiv
e cells were markedly increased in the capsular area of nodules containing
female worms with embryos and microfilariae compared to untreated nodules.
In the centre of these nodules, around the adult Onchocerca volvulus, we fo
und many tryptase-positive cells. More mast cells were IgE-positive than in
untreated nodules, equalling the number of tryptase-positive mast cells. T
here was a clear correlation between the appearance of mast cells and the a
ttacks on damaged microfilariae by eosinophils and macrophages and in the v
icinity of adult worms by neutrophils that occur soon after ivermectin trea
tment. Onchocercomata harbouring female worms with oocytes only revealed, a
fter all treatment intervals, the same mast cell numbers as untreated nodul
es. In conclusion,during the first three days after administration, ivermec
tin produces increased numbers of mast cells in nodules harbouring females
with embryos and microfilariae, probably as part of an allergic reaction to
the attacked microfilariae. Four to 19 days after ivermectin the number of
mast cells in the entire nodule is no longer elevated.